CASI Pharmaceuticals Inc (CASI) is around the top of the Biotechnology industry according to InvestorsObserver. CASI received an overall rating of 61, which means that it scores higher than 61 percent of all stocks. CASI Pharmaceuticals Inc also achieved a score of 77 in the Biotechnology industry, putting it above 77 percent of Biotechnology stocks. Biotechnology is ranked 45 out of the 148 industries.
CASI has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on CASI!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 61 means the stock is more attractive than 61 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With CASI Pharmaceuticals Inc Stock Today?
CASI Pharmaceuticals Inc (CASI) stock is trading at $2.68 as of 10:08 AM on Tuesday, Jul 18, an increase of $0.03, or 1.13% from the previous closing price of $2.65. The stock has traded between $2.68 and $2.77 so far today. Volume today is light. So far 1,372 shares have traded compared to average volume of 48,900 shares.
Click Here to get the full Stock Report for CASI Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
